HSV Infection
2
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket
Drug Modality Breakdown
Small Molecule
2100%
Competitive Landscape
1 companies ranked by most advanced pipeline stage
AiCurisGermany - Wuppertal
2 programs1
1
PritelivirPhase 3Small Molecule1 trial
PritelivirPhase 1Small Molecule1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
AiCurisPritelivir
AiCurisPritelivir
Clinical Trials (2)
Trial on Efficacy and Safety of Pritelivir Tablets for Treatment of Acyclovir-resistant Mucocutaneous HSV (Herpes Simplex Virus) Infections in Immunocompromised Subjects
Start: May 2017Est. completion: Nov 2025
Phase 3Completed
Potential Influence of Esomeprazole on the Pharmacokinetics of Pritelivir
Start: Jul 2020Est. completion: Oct 2020
Phase 1Completed
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 late-stage (Phase 3) programs — potential near-term approvals
1 companies competing in this space